efficacy 1
safety 1
dupilumab 2
adults 2
moderatetosevere 2
atopic 2
dermatitis 2
inadequately 1
controlled 1
topical 1
treatments 1
randomised 1
placebocontrolled 1
doseranging 1
phase 1
b 1
trial 1
treatment 1
